corneal opacity/albumin

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

5 niðurstöður

A transient stage of suspected delayed sensitivity during the early induction phase of immediate corneal sensitivity.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

1. If quantities of bovine serum albumin or bovine gamma globulin in the range of 2 to 4 mg are inoculated intracorneally into rabbits, a biphasic reaction occurs in the cornea. 2. The primary reaction, which becomes manifest approximately 3 days after inoculation and lasts several days, is

Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE Beta igh3 is a transforming growth factor-beta-inducible cell adhesion molecule and its mutations are responsible for human autosomal dominant corneal dystrophies. Previously, we have studied the molecular properties of beta igh3 in vitro and reported that beta igh3 polymerizes to form a

Theileriasis in crossbred cows and its therapeutic management: first report from Lushai hill district of Mizoram.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

To know the prevalence of theileriosis infection, haemato-biochemical alteration and efficacy of Oxytetracycline in combination with Diaminazene aceturate injection against theileriosis in Lushai hill district of Mizoram; fifty five cross bred cattle were screened during July, 2013 to November,

Recurrent immunogenic interstitial keratitis. Production in the guinea pig by extraocular means.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Combinations of intracutaneous (IC) and intravenous (IV) injections of bovine gamma-globulin (BGG) or bovine serum albumin (BSA) induced interstitial keratitis in 24 of 29 guinea pigs. For IC injection, antigen was incorporated in complete Freund adjuvant. When IC and IV BGG reactants were

[A 52-week oral toxicity study of a new antineoplastic agent S-1 in dogs].

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

52-week oral repeated-dose S-1 toxicity studies were conducted. Male and female dogs were orally treated with 0, 0.1, 0.5 or 2.5 mg/kg/day for 52 weeks and permitted to recover for 13 weeks. Furthermore, to estimate the no-toxic dose, male and female dogs were given S-1 orally for 52 weeks at doses

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum